Martin R. Curiel
@Myecfo, Llc
Latest period2024 - Q4ReportedManaged Assets$185.27MTotal holdings57
Assets growth rate0.37%Assets growth rate (2-Q avg)3.42%Continuous growth in asset value6 quarters
Portfolio positions
This chart displays the top 10 holdings in Myecfo, Llc's 2024 - Q4 portfolio, based on their 13F SEC filing, out of a total of 57 positions.
Assets under management
The assets under management (AUM) of Myecfo, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 6 quarters. As of the latest 13F SEC filing for 2024 - Q4, they manage 185.27M in assets, with a quarterly growth rate of 0.37% and a 2-quarter average growth rate of 3.42%. The portfolio is managed by Martin R. Curiel, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
SCHYSchwab Strategic Tr
| 0.27% | $484,873 20,972 shares@ $23.13 avg price | Increased 1.46% |
VIGVanguard Specialized Funds
| 0.25% | $462,942 2,364 shares@ $195.83 avg price | Decreased -5.77% |
NVDANvidia Corporation
| 0.25% | $456,855 3,402 shares@ $134.3 avg price | Increased 4.62% |
METAMeta Platforms Inc
| 0.25% | $449,086 767 shares@ $585.51 avg price | Increased 3.24% |
DSIIshares Tr
| 0.23% | $420,053 3,810 shares@ $110.26 avg price | Increased 20.57% |
VPUVanguard World Fd
| 0.22% | $403,974 2,472 shares@ $163.42 avg price | Increased 11.76% |
MSFTMicrosoft Corp
| 0.21% | $385,266 914 shares@ $421.52 avg price | |
VOVanguard Index Fds
| 0.2% | $367,141 1,390 shares@ $264.14 avg price | Increased 23.01% |
ARWRArrowhead Pharmaceuticals In
| 0.19% | $347,744 18,497 shares@ $18.81 avg price | |
VDEVanguard World Fd
| 0.18% | $322,321 2,657 shares@ $121.32 avg price | Increased 5.57% |